Description
Bijuve is a continuous combined form of hormone replacement therapy (HRT), designed for postmenopausal women with an intact uterus who are experiencing symptoms such as hot flushes, night sweats, mood changes, and vaginal dryness. It is the first and only oral HRT to combine bioidentical oestradiol (a plant-derived form of oestrogen) with bioidentical progesterone in a single daily capsule, offering a more natural hormone therapy option.
How It Works
Bijuve contains two hormones: oestradiol (a naturally occurring form of oestrogen) and micronised progesterone (a naturally occurring form of progesterone).
Oestradiol replenishes declining oestrogen levels during menopause, helping to relieve symptoms such as hot flushes, sleep disturbances, and urogenital discomfort.
Progesterone protects the lining of the womb from overgrowth caused by oestrogen, reducing the risk of endometrial cancer.
Because Bijuve is a continuous combined therapy, both hormones are taken every day without a break, helping to prevent monthly withdrawal bleeds while maintaining symptom relief.
Why Choose Bijuve
Bioidentical hormones – identical in molecular structure to the body’s own hormones.
Convenient once-daily capsule with both oestradiol and progesterone combined.
Suitable for women seeking a more natural form of HRT while still benefiting from regulated prescription standards.
May improve tolerability for women who experience side effects with synthetic progestogens.
Important Note
Bijuve should only be taken under the guidance of a healthcare professional. It is not suitable for women with a history of hormone-dependent cancers, unexplained vaginal bleeding, untreated high blood pressure, blood clotting disorders, liver disease, or certain other medical conditions.
Long-term HRT use may be associated with increased risks, including cardiovascular events, stroke, and breast cancer. Risks and benefits should be reviewed regularly with your doctor.
